Sofinnova closes 725 million euro crossover fund. Sofinnova Partners has closed its second crossover fund at 725 million euros for late stage European biotech companies, Endpoints News and BioPharma Dive reported. The fund gives the Paris firm dedicated capital for the crossover rounds that carry private European drug developers into public markets, a segment where European supply has been thin.
Apple and OpenEvidence launch health chat study. Apple and OpenEvidence have launched an experimental health chat app, reported by STAT and TechCrunch, with Apple framing it as a study of how people use AI for health questions. The launch puts a consumer health chatbot from the largest device maker into direct comparison with the clinical tools already in use.
MHRA publishes Women’s Health Programme. The UK Medicines and Healthcare products Regulatory Agency published its Women’s Health Programme for 2026 to 2030 as a corporate report. The programme sets the regulator’s priorities for women’s health products over the next four years.